Insomnia comorbid with mental health conditions acquires structured therapy options
Daridorexant maturity, cognitive-behavioural therapy for insomnia (CBT-I) digital expansion, and integrated mental-health-and-insomnia treatment models are reshaping comorbid insomnia care.
Insomnia comorbid with depression, anxiety, PTSD, and other mental health conditions has been managed with the underlying-condition therapy plus sleep medication selected ad hoc. Daridorexant and other dual orexin receptor antagonists provide chronic-use options without dependence concerns of older sleep medicines. Digital CBT-I (cognitive-behavioural therapy for insomnia) widens behavioural-therapy access. Integrated mental-health-and-insomnia treatment models are emerging as the better-outcomes approach.
Continue reading
Full intelligence on PanaceaIntel
PatientSpotlight publishes the headline framing. The full brief, the editorial takeaway, and the source list sit on PanaceaIntel for entitled clients.
New to PanaceaIntel? Request access and the team will reply within one working day.